Cancer cells also secrete platelet agonists such as adenosine diphosphate (ADP) and thrombin, thus further promoting platelet activation through P2Y12 and protease-activated receptors 1 and 4 (PAR1/4), respectively [54]. Here, F2R is linked to cancer.